Over 25% of sarcoma occur in the limbs
Most physiotherapists never expect to see sarcoma – the cancer that mimics MSK injury. But your expertise in musculoskeletal health makes you a key partner in early sarcoma recognition and holistic patient care.
Sarcoma is rare, but your patients may present with lumps, pain or unusual symptoms that need timely referral. Our resources help you confidently identify red flags and support patients through complex rehabilitation.
How Sarcoma UK can support you
We have a range of resources to help you recognise the signs of sarcoma and support patient rehabilitation.
Our Guide for Allied Health Professionals (AHPs) was written in collaboration with AHPs to give you the confidence to manage the complexities of sarcoma care.
Support at your fingertips
Our Support Line is primarily for people affected by sarcoma, but we also welcome calls from healthcare professionals seeking guidance or signposting to resources: 0808 801 0401.
Order your Sarcoma Awareness Month Healthcare Professionals’ Pack to raise awareness in your setting.
We’re often the first port of call.
Lucy Dean, Physiotherapist
Sarcoma Awareness Month 2025
We promote Sarcoma Awareness Month every year in July, to raise awareness of sarcoma and the importance of early diagnosis.
For 2025, we are focusing on healthcare professionals – the people best placed to spot the early signs of sarcoma. From GPs and physiotherapists to radiologists and AHPs, we’re sharing practical guidance, training resources and real stories from peers working with sarcoma.
Why Sarcoma UK?
We are the UK’s national sarcoma charity, funding vital research, offering support to those affected by sarcoma, and campaigning for better treatments.
We’re dedicated to working with professionals like you to improve patient outcomes.
Why Sarcoma UK?
We are the UK’s national sarcoma charity, funding vital research, offering support to those affected by sarcoma, and campaigning for better treatments.
We’re dedicated to working with professionals like you to improve patient outcomes.
